IBDEI0PW ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,11641,1,3,0)
;;=3^Nephritic Syndrome w/ Morphologic Changes,Acute
;;^UTILITY(U,$J,358.3,11641,1,4,0)
;;=4^N00.9
;;^UTILITY(U,$J,358.3,11641,2)
;;=^5015500
;;^UTILITY(U,$J,358.3,11642,0)
;;=N08.^^46^565^2
;;^UTILITY(U,$J,358.3,11642,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11642,1,3,0)
;;=3^Glomerular Disorders in Diseases Classified Elsewhere
;;^UTILITY(U,$J,358.3,11642,1,4,0)
;;=4^N08.
;;^UTILITY(U,$J,358.3,11642,2)
;;=^5015569
;;^UTILITY(U,$J,358.3,11643,0)
;;=N03.9^^46^565^4
;;^UTILITY(U,$J,358.3,11643,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11643,1,3,0)
;;=3^Nephritic Syndrome w/ Morphologic Changes,Chronic
;;^UTILITY(U,$J,358.3,11643,1,4,0)
;;=4^N03.9
;;^UTILITY(U,$J,358.3,11643,2)
;;=^5015530
;;^UTILITY(U,$J,358.3,11644,0)
;;=N05.8^^46^566^1
;;^UTILITY(U,$J,358.3,11644,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11644,1,3,0)
;;=3^Nephritic Syndrome w/ Morphologic Changes,Unspec
;;^UTILITY(U,$J,358.3,11644,1,4,0)
;;=4^N05.8
;;^UTILITY(U,$J,358.3,11644,2)
;;=^5134085
;;^UTILITY(U,$J,358.3,11645,0)
;;=M30.0^^46^567^2
;;^UTILITY(U,$J,358.3,11645,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11645,1,3,0)
;;=3^Polyarteritis Nodosa
;;^UTILITY(U,$J,358.3,11645,1,4,0)
;;=4^M30.0
;;^UTILITY(U,$J,358.3,11645,2)
;;=^5011738
;;^UTILITY(U,$J,358.3,11646,0)
;;=N04.9^^46^567^1
;;^UTILITY(U,$J,358.3,11646,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11646,1,3,0)
;;=3^Nephrotic Syndrome w/ Morphologic Changes
;;^UTILITY(U,$J,358.3,11646,1,4,0)
;;=4^N04.9
;;^UTILITY(U,$J,358.3,11646,2)
;;=^5015540
;;^UTILITY(U,$J,358.3,11647,0)
;;=N13.30^^46^568^2
;;^UTILITY(U,$J,358.3,11647,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11647,1,3,0)
;;=3^Hydronephrosis,Unspec
;;^UTILITY(U,$J,358.3,11647,1,4,0)
;;=4^N13.30
;;^UTILITY(U,$J,358.3,11647,2)
;;=^5015578
;;^UTILITY(U,$J,358.3,11648,0)
;;=N13.9^^46^568^12
;;^UTILITY(U,$J,358.3,11648,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11648,1,3,0)
;;=3^Uropathy,Obstructive & Reflux,Unspec
;;^UTILITY(U,$J,358.3,11648,1,4,0)
;;=4^N13.9
;;^UTILITY(U,$J,358.3,11648,2)
;;=^5015589
;;^UTILITY(U,$J,358.3,11649,0)
;;=N40.1^^46^568^1
;;^UTILITY(U,$J,358.3,11649,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11649,1,3,0)
;;=3^Enlarged Prostate w/ LUTS
;;^UTILITY(U,$J,358.3,11649,1,4,0)
;;=4^N40.1
;;^UTILITY(U,$J,358.3,11649,2)
;;=^5015690
;;^UTILITY(U,$J,358.3,11650,0)
;;=R39.14^^46^568^3
;;^UTILITY(U,$J,358.3,11650,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11650,1,3,0)
;;=3^Incomplete Bladder Emptying
;;^UTILITY(U,$J,358.3,11650,1,4,0)
;;=4^R39.14
;;^UTILITY(U,$J,358.3,11650,2)
;;=^5019344
;;^UTILITY(U,$J,358.3,11651,0)
;;=R35.1^^46^568^4
;;^UTILITY(U,$J,358.3,11651,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11651,1,3,0)
;;=3^Nocturia
;;^UTILITY(U,$J,358.3,11651,1,4,0)
;;=4^R35.1
;;^UTILITY(U,$J,358.3,11651,2)
;;=^5019335
;;^UTILITY(U,$J,358.3,11652,0)
;;=R39.16^^46^568^5
;;^UTILITY(U,$J,358.3,11652,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11652,1,3,0)
;;=3^Straining on Urinartion
;;^UTILITY(U,$J,358.3,11652,1,4,0)
;;=4^R39.16
;;^UTILITY(U,$J,358.3,11652,2)
;;=^5019346
;;^UTILITY(U,$J,358.3,11653,0)
;;=R35.0^^46^568^6
;;^UTILITY(U,$J,358.3,11653,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11653,1,3,0)
;;=3^Urinary Frequency
;;^UTILITY(U,$J,358.3,11653,1,4,0)
;;=4^R35.0
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0PW 3771 printed Dec 13, 2024@01:53:27 Page 2
IBDEI0PW ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,11641,1,3,0)
+2 ;;=3^Nephritic Syndrome w/ Morphologic Changes,Acute
+3 ;;^UTILITY(U,$J,358.3,11641,1,4,0)
+4 ;;=4^N00.9
+5 ;;^UTILITY(U,$J,358.3,11641,2)
+6 ;;=^5015500
+7 ;;^UTILITY(U,$J,358.3,11642,0)
+8 ;;=N08.^^46^565^2
+9 ;;^UTILITY(U,$J,358.3,11642,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,11642,1,3,0)
+12 ;;=3^Glomerular Disorders in Diseases Classified Elsewhere
+13 ;;^UTILITY(U,$J,358.3,11642,1,4,0)
+14 ;;=4^N08.
+15 ;;^UTILITY(U,$J,358.3,11642,2)
+16 ;;=^5015569
+17 ;;^UTILITY(U,$J,358.3,11643,0)
+18 ;;=N03.9^^46^565^4
+19 ;;^UTILITY(U,$J,358.3,11643,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,11643,1,3,0)
+22 ;;=3^Nephritic Syndrome w/ Morphologic Changes,Chronic
+23 ;;^UTILITY(U,$J,358.3,11643,1,4,0)
+24 ;;=4^N03.9
+25 ;;^UTILITY(U,$J,358.3,11643,2)
+26 ;;=^5015530
+27 ;;^UTILITY(U,$J,358.3,11644,0)
+28 ;;=N05.8^^46^566^1
+29 ;;^UTILITY(U,$J,358.3,11644,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,11644,1,3,0)
+32 ;;=3^Nephritic Syndrome w/ Morphologic Changes,Unspec
+33 ;;^UTILITY(U,$J,358.3,11644,1,4,0)
+34 ;;=4^N05.8
+35 ;;^UTILITY(U,$J,358.3,11644,2)
+36 ;;=^5134085
+37 ;;^UTILITY(U,$J,358.3,11645,0)
+38 ;;=M30.0^^46^567^2
+39 ;;^UTILITY(U,$J,358.3,11645,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,11645,1,3,0)
+42 ;;=3^Polyarteritis Nodosa
+43 ;;^UTILITY(U,$J,358.3,11645,1,4,0)
+44 ;;=4^M30.0
+45 ;;^UTILITY(U,$J,358.3,11645,2)
+46 ;;=^5011738
+47 ;;^UTILITY(U,$J,358.3,11646,0)
+48 ;;=N04.9^^46^567^1
+49 ;;^UTILITY(U,$J,358.3,11646,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,11646,1,3,0)
+52 ;;=3^Nephrotic Syndrome w/ Morphologic Changes
+53 ;;^UTILITY(U,$J,358.3,11646,1,4,0)
+54 ;;=4^N04.9
+55 ;;^UTILITY(U,$J,358.3,11646,2)
+56 ;;=^5015540
+57 ;;^UTILITY(U,$J,358.3,11647,0)
+58 ;;=N13.30^^46^568^2
+59 ;;^UTILITY(U,$J,358.3,11647,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,11647,1,3,0)
+62 ;;=3^Hydronephrosis,Unspec
+63 ;;^UTILITY(U,$J,358.3,11647,1,4,0)
+64 ;;=4^N13.30
+65 ;;^UTILITY(U,$J,358.3,11647,2)
+66 ;;=^5015578
+67 ;;^UTILITY(U,$J,358.3,11648,0)
+68 ;;=N13.9^^46^568^12
+69 ;;^UTILITY(U,$J,358.3,11648,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,11648,1,3,0)
+72 ;;=3^Uropathy,Obstructive & Reflux,Unspec
+73 ;;^UTILITY(U,$J,358.3,11648,1,4,0)
+74 ;;=4^N13.9
+75 ;;^UTILITY(U,$J,358.3,11648,2)
+76 ;;=^5015589
+77 ;;^UTILITY(U,$J,358.3,11649,0)
+78 ;;=N40.1^^46^568^1
+79 ;;^UTILITY(U,$J,358.3,11649,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,11649,1,3,0)
+82 ;;=3^Enlarged Prostate w/ LUTS
+83 ;;^UTILITY(U,$J,358.3,11649,1,4,0)
+84 ;;=4^N40.1
+85 ;;^UTILITY(U,$J,358.3,11649,2)
+86 ;;=^5015690
+87 ;;^UTILITY(U,$J,358.3,11650,0)
+88 ;;=R39.14^^46^568^3
+89 ;;^UTILITY(U,$J,358.3,11650,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,11650,1,3,0)
+92 ;;=3^Incomplete Bladder Emptying
+93 ;;^UTILITY(U,$J,358.3,11650,1,4,0)
+94 ;;=4^R39.14
+95 ;;^UTILITY(U,$J,358.3,11650,2)
+96 ;;=^5019344
+97 ;;^UTILITY(U,$J,358.3,11651,0)
+98 ;;=R35.1^^46^568^4
+99 ;;^UTILITY(U,$J,358.3,11651,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,11651,1,3,0)
+102 ;;=3^Nocturia
+103 ;;^UTILITY(U,$J,358.3,11651,1,4,0)
+104 ;;=4^R35.1
+105 ;;^UTILITY(U,$J,358.3,11651,2)
+106 ;;=^5019335
+107 ;;^UTILITY(U,$J,358.3,11652,0)
+108 ;;=R39.16^^46^568^5
+109 ;;^UTILITY(U,$J,358.3,11652,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,11652,1,3,0)
+112 ;;=3^Straining on Urinartion
+113 ;;^UTILITY(U,$J,358.3,11652,1,4,0)
+114 ;;=4^R39.16
+115 ;;^UTILITY(U,$J,358.3,11652,2)
+116 ;;=^5019346
+117 ;;^UTILITY(U,$J,358.3,11653,0)
+118 ;;=R35.0^^46^568^6
+119 ;;^UTILITY(U,$J,358.3,11653,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,11653,1,3,0)
+122 ;;=3^Urinary Frequency
+123 ;;^UTILITY(U,$J,358.3,11653,1,4,0)
+124 ;;=4^R35.0
